1 month RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Consensus Recommendation of “Hold” by BrokeragesMarketBeat
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stoc…
X